Merck Goodwill and Intangible Assets 2010-2024 | MKKGY
Merck goodwill and intangible assets from 2010 to 2024. Goodwill and intangible assets can be defined as the sum of all intangible asset fields
- Merck goodwill and intangible assets for the quarter ending June 30, 2024 were $26.415B, a 2.58% decline year-over-year.
- Merck goodwill and intangible assets for 2023 were $26.404B, a 2.55% decline from 2022.
- Merck goodwill and intangible assets for 2022 were $27.095B, a 6.96% decline from 2021.
- Merck goodwill and intangible assets for 2021 were $29.123B, a 7.98% increase from 2020.
Merck Annual Goodwill and Intangible Assets
(Millions of US $) |
| 2023 |
$26,404 |
| 2022 |
$27,095 |
| 2021 |
$29,123 |
| 2020 |
$26,972 |
| 2019 |
$29,474 |
| 2018 |
$24,802 |
| 2017 |
$24,752 |
| 2016 |
$27,653 |
| 2015 |
$28,119 |
| 2014 |
$15,148 |
| 2013 |
$13,107 |
| 2012 |
$14,076 |
| 2011 |
$16,388 |
| 2010 |
$ |
| 2009 |
$ |
Merck Quarterly Goodwill and Intangible Assets
(Millions of US $) |
| 2024-06-30 |
$26,415 |
| 2024-03-31 |
$26,776 |
| 2023-12-31 |
$26,404 |
| 2023-09-30 |
$27,408 |
| 2023-06-30 |
$27,115 |
| 2023-03-31 |
$26,868 |
| 2022-12-31 |
$27,095 |
| 2022-09-30 |
$27,813 |
| 2022-06-30 |
$28,132 |
| 2022-03-31 |
$28,403 |
| 2021-12-31 |
$29,123 |
| 2021-09-30 |
$28,652 |
| 2021-06-30 |
$28,869 |
| 2021-03-31 |
$29,303 |
| 2020-12-31 |
$26,972 |
| 2020-09-30 |
$28,856 |
| 2020-06-30 |
$28,389 |
| 2020-03-31 |
$29,196 |
| 2019-12-31 |
$29,474 |
| 2019-09-30 |
$23,395 |
| 2019-06-30 |
$23,166 |
| 2019-03-31 |
$23,872 |
| 2018-12-31 |
$24,802 |
| 2018-09-30 |
$24,629 |
| 2018-06-30 |
$25,637 |
| 2018-03-31 |
$26,012 |
| 2017-12-31 |
$24,752 |
| 2017-09-30 |
$26,307 |
| 2017-06-30 |
$25,453 |
| 2017-03-31 |
$26,284 |
| 2016-12-31 |
$27,653 |
| 2016-09-30 |
$26,759 |
| 2016-06-30 |
$27,583 |
| 2016-03-31 |
$26,951 |
| 2015-12-31 |
$28,119 |
| 2015-09-30 |
$12,691 |
| 2015-06-30 |
$12,988 |
| 2015-03-31 |
$13,243 |
| 2014-12-31 |
$15,148 |
| 2014-09-30 |
$15,300 |
| 2014-06-30 |
$15,673 |
| 2014-03-31 |
$13,278 |
| 2013-12-31 |
$13,107 |
| 2013-09-30 |
$13,620 |
| 2013-06-30 |
$13,804 |
| 2013-03-31 |
$14,299 |
| 2012-12-31 |
$14,076 |
| 2012-09-30 |
$13,984 |
| 2012-06-30 |
$14,688 |
| 2012-03-31 |
|
| 2011-12-31 |
$16,388 |
| 2011-09-30 |
|
| 2011-06-30 |
$16,840 |
| 2011-03-31 |
|
| 2010-12-31 |
|
| 2010-09-30 |
$16,584 |
| 2010-06-30 |
|
| 2010-03-31 |
|
| 2009-12-31 |
|
| 2009-09-30 |
|
| 2009-06-30 |
|
| 2009-03-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$21.306B |
$22.719B |
|
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
|
